“…The long‐time established use of plant extracts to treat human infections directed researchers to search for antibacterial agents from plant sources, or their hemisynthezised derivates, a promising approach, corroborated by the number of papers published in recent years (Newman and Cragg, ; van Vuuren and Viljoen, ). Among natural compounds, abietane diterpenes with phenolic and quinonic moieties are known to be interesting plant metabolites with diverse pharmacological activities, namely, antimicrobial (Radulović et al ., ; Hanson, ; van Vuuren, ; Hanson, ; Hanson, ; Hanson, ; Hanson, ), antitubercular (Rijo et al ., ; Hanson, ) and cytotoxic (Fronza et al ., ; Hanson, ; Hanson, ). However, a literature survey does not reveal significant attempts to modulate these activities on royleanone abietanes.…”